PATENT CLAIM ANALYSIS

Application Number: 15984146
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "049000"]

Abstract:
The present disclosure provides compositions that include a nanoparticle and a compound that reduces the biological activity of one or more bromodomain and extra-terminal family member (BET) proteins (e.g., a bromodomain inhibitor), and methods of using such compounds to increase retention or storage of vitamin A, vitamin D, and/or lipids by a cell, such as an epithelial or stellate cell.

Claim (Index 19):
The method of  claim 18 , wherein the pancreatic disease is pancreatic fibrosis, pancreatic ductal adenocarcinoma (PDA).

Metadata:
- Claim Count in Document: 51.0
- Percentile: 93.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15807424', '14921230', '12772981', '14959105', '14651413']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7846716928392656
- 35 USC 102 Novelty (BERT): 0.5474810210698163
- Combined Prediction Score: 0.7609526256623208
- Mean Citation Score: 294.6769020000001
- Max Citation Score: 412.19766
- Similarity Product: 285.02318698846216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test